Sandbox Reserved 1073
From Proteopedia
(Difference between revisions)
| Line 5: | Line 5: | ||
== Introduction == | == Introduction == | ||
| - | The Enoyl-ACP Reductase InhA, from [http://en.wikipedia.org/wiki/Mycobacterium_tuberculosis ''Mycobacterium tuberculosis''], catalyzes the [http://en.wikipedia.org/wiki/Nicotinamide_adenine_dinucleotide NADH]-dependent reduction of long-chain ''trans''-2-enoyl-ACP fatty acids in the type II fatty acid biosynthesis pathway of ''M.'' ''tuberculosis''. InhA is a member of the [http://en.wikipedia.org/wiki/Short-chain_dehydrogenase short chain dehydrogenase/reductase] (SDR) family of enzymes. | + | The Enoyl-ACP Reductase InhA, from [http://en.wikipedia.org/wiki/Mycobacterium_tuberculosis ''Mycobacterium tuberculosis''], catalyzes the [http://en.wikipedia.org/wiki/Nicotinamide_adenine_dinucleotide NADH]-dependent reduction of long-chain ''trans''-2-enoyl-ACP fatty acids in the type II fatty acid biosynthesis pathway of ''M.'' ''tuberculosis''. InhA is a member of the [http://en.wikipedia.org/wiki/Short-chain_dehydrogenase short chain dehydrogenase/reductase] (SDR) family of enzymes. InhA is the only enoyl-ACP reductase found in tuberculosis, making the enzyme a potential drug target. |
=== FAS-II System === | === FAS-II System === | ||
Revision as of 12:54, 31 March 2015
| This Sandbox is Reserved from 02/09/2015, through 05/31/2016 for use in the course "CH462: Biochemistry 2" taught by Geoffrey C. Hoops at the Butler University. This reservation includes Sandbox Reserved 1051 through Sandbox Reserved 1080. |
To get started:
More help: Help:Editing |
Enoyl-ACP Reductase InhA
| |||||||||||
